Pharmacotherapy in the treatment of addiction: methadone.
about
Burden and nutritional deficiencies in opiate addiction- systematic review articleImmunotherapy for drug abuseUse of pharmacotherapies in the treatment of alcohol use disorders and opioid dependence in primary careMethadone for neuropathic pain in adultsA randomized pilot clinical trial to evaluate the efficacy of Community Reinforcement and Family Training for Treatment Retention (CRAFT-T) for improving outcomes for patients completing opioid detoxification.In silico ordinary differential equation/partial differential equation hemodialysis model estimates methadone removal during dialysisOpioids and Opioid Maintenance Therapies: Their Impact on Monocyte-Mediated HIV Neuropathogenesis.Anti-cocaine vaccine development.Can you vaccinate against substance abuse?Anti-addiction vaccines.Improving public health through access to and utilization of medication assisted treatmentMethadone dose in heroin-dependent patients: role of clinical factors, comedications, genetic polymorphisms and enzyme activityVaccines against drug abuse.Increases in the availability of prescribed opioids in a Canadian setting.Substance Abuse Treatment, HIV/AIDS, and the Continuum of Response for People Who Inject Drugs.Challenging biopower: "Liquid cuffs" and the "Junkie" habitusPerceived relapse risk and desire for medication assisted treatment among persons seeking inpatient opiate detoxification.A morphine conjugate vaccine attenuates the behavioral effects of morphine in rats.Association of genetic variation in pharmacodynamic factors with methadone dose required for effective treatment of opioid addiction.The association between age of onset of opioid use and comorbidity among opioid dependent patients receiving methadone maintenance therapy.Nicotine vaccines to treat tobacco dependence.New view on treatment of drug dependence.Transporter-Mediated Disposition of Opioids: Implications for Clinical Drug Interactions.Pharmacoepigenomics of opiates and methadone maintenance treatment: current data and perspectives.Network-assisted prediction of potential drugs for addiction.NIDA Clinical Trials Network CTN-0051, Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT): Study design and rationale.Effect of prison-based opioid substitution treatment and post-release retention in treatment on risk of re-incarceration.Opioid-related mortality and filled prescriptions for buprenorphine and methadone.Missense mutation at CLDN8 associated with a high plasma interferon gamma-inducible protein 10 level in methadone-maintained patients with urine test positive for morphine.Why People Who Inject Drugs Voluntarily Transition Off Methadone in Ukraine.Nitric oxide-heat shock protein axis in menopausal hot flushes: neglected metabolic issues of chronic inflammatory diseases associated with deranged heat shock response.Auditory event-related potentials in methadone substituted opiate users.Associations between pharmacotherapy for opioid dependence and clinical and criminal justice outcomes among adults with co-occurring serious mental illness.Methadone Recycling Sustains Drug Reservoir in Tissue.Variability of response to methadone: genome-wide DNA methylation analysis in two independent cohorts.
P2860
Q26851897-2E0D5095-2E7C-450A-86ED-D869C6B7242DQ26853633-40C21CCF-2625-417B-B876-7291839F2860Q28081029-3FBA1107-6238-48BE-8532-BFB6D7011B36Q29994484-BD44138E-329F-47DA-8AEC-02CC0B2BAED9Q30578204-62DEF1F4-14B7-4A9C-9DDE-7422CF265EF0Q30659058-15E46115-DAFC-4D3D-A8E8-7AEF76B61694Q33842214-76DECE4D-3936-4A85-8C98-6D3F04C56CC0Q34023863-DB27D927-7019-473F-A5AA-F1267A343777Q34132788-FB386241-C99B-408C-84DF-430762AC0BC9Q35263981-D7719E1B-9AD6-4D63-93A5-9F00BA6BAD2EQ35534893-C0A2048C-2DBC-482B-AE51-9BE187987BB7Q35684822-0EA1356D-6FD3-49E7-B293-5E36BFEA377BQ35938624-21F67980-F751-4361-85D8-1597D5CE6736Q36089748-7D95109F-699C-45DA-A533-888B9DA5A079Q36454818-8450C558-5307-4551-8B03-56C9CFF8F36AQ36658101-5D76743C-04D1-46C8-B0D8-B3BB8875372BQ36920487-3C5A0DA0-8535-4E30-88B2-16B8801D998BQ37172159-32EF0B38-47C6-44E6-9FC8-F158188CE9E6Q37401604-F0A26322-0A11-4EF0-8889-69A2B8EA5295Q37724712-777BF5C5-997C-4BE7-B630-CD8888894B99Q38056382-CC25711A-8606-4904-BB97-86DA1348F2B1Q38272992-96C6DFBC-DC3A-438B-9F8B-B507F2CF28FBQ38478413-047622F7-0E1C-419A-9F40-7DAD40084440Q38608450-9D4E96DE-AE51-4EAF-9866-5A0F4A25E7F7Q39218459-EF7236FE-4DD7-4CE3-A9E5-C308078A9019Q42289728-7348A0BC-B571-4731-91A5-CF0FB70C5364Q44330216-1A33F963-0FDC-48DF-AE85-6DDF9E3F0630Q44344490-30F819E3-A6EF-45F0-A0CC-9044AA9BA740Q47395797-52D5C23E-AAF9-405C-A455-7234FA717C83Q47568447-35BFC647-7CE0-4F90-ACD7-890707F750F6Q47807793-E4589311-6CD1-47C2-B8BA-00EA8B57E51FQ48147572-88C5387B-4D2C-43FA-B77B-2DDDD30575C6Q50130680-49AD10F7-7214-41CB-A774-16664872B140Q52307782-173046FC-D4FA-4996-AA26-97E6F2F74FBAQ52308504-8D17FF4A-89E6-4959-9924-6CD4C8408794
P2860
Pharmacotherapy in the treatment of addiction: methadone.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Pharmacotherapy in the treatment of addiction: methadone.
@ast
Pharmacotherapy in the treatment of addiction: methadone.
@en
type
label
Pharmacotherapy in the treatment of addiction: methadone.
@ast
Pharmacotherapy in the treatment of addiction: methadone.
@en
prefLabel
Pharmacotherapy in the treatment of addiction: methadone.
@ast
Pharmacotherapy in the treatment of addiction: methadone.
@en
P2093
P2860
P1476
Pharmacotherapy in the treatment of addiction: methadone.
@en
P2093
Brenda Ray
Elizabeth Ducat
P2860
P304
P356
10.1080/10550881003684798
P577
2010-04-01T00:00:00Z